Statistics

Total Visits

Views
A phase II study of capecitabine in combination with erlotinib as first-line therapy in patients with metastatic pancreatic cancer (stage IV)92

Select a period of time:

Number of views in the range

Views
A phase II study of capecitabine in combination with erlotinib as first-line therapy in patients with metastatic pancreatic cancer (stage IV)35

Views

Views
April 20253
May 20254
June 20255
July 202519
August 20252
September 20252
October 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States18
Brazil11
United Kingdom4
Spain1
Trinidad and Tobago1
 

Top cities views

Views
Santa Maria2
Chicago2
Barra Bonita1
Caraúbas1
Carutapera1
Chaguanas1
Cincinnati1
Council Bluffs1
Dallas1
Detroit1